Search our Database of Scientific Publications and Authors

I’m looking for a
    Long-term effects of porcine zonae pellucidae immunocontraception on ovarian function in feral horses (Equus caballus).
    J Reprod Fertil 1992 Mar;94(2):437-44
    Deaconess Research Institute, Billings, MT 59102.
    Ten feral mares free-roaming in Maryland, USA, were inoculated with porcine zonae pellucidae (PZP) protein before the breeding season for three consecutive years (1988-90). Ovarian function was monitored for 51 days during the peak of the breeding season after the third annual PZP inoculation, in seven of these mares and in four untreated control mares, by means of urinary oestrone conjugates and nonspecific progesterone metabolites. None of the ten inoculated mares became pregnant in 1990, compared with 55% of 20 control mares, which included two of the four monitored for ovarian function. Three of the untreated mares demonstrated apparent normal ovarian activity, characterized by preovulatory oestrogen peaks, concurrent progesterone nadirs at ovulation, breeding activity, and luteal-phase progesterone increases after ovulation. Two of the seven monitored PZP-treated mares demonstrated ovulatory cycles that did not result in conception. One was pregnant as a result of conception in 1989 and demonstrated a normal, late-gestation, endocrine profile. The remaining four PZP-treated mares revealed no evidence of ovulation, and urinary oestrogen concentrations were significantly depressed. The experiments indicated that (i) a third consecutive annual PZP booster inoculation is greater than 90% effective in preventing pregnancies in mares and (ii) three consecutive years of PZP treatment may interfere with normal ovarian function as shown by markedly depressed oestrogen secretion.

    Similar Publications

    Antigen recognition in feral mares previously immunized with porcine zonae pellucidae.
    J Reprod Fertil Suppl 1991 ;44:321-5
    Department of Biological Sciences, Eastern Montana College, Billings 59101.
    Twenty-six free-roaming feral mares were immunized against porcine zonae pellucidae (PZP) between February and May, 1988. Eight sexually mature mares received 2 inoculations 2 weeks apart, and 18 mares received 3 inoculations at intervals of 2 and 4 weeks. Analysis of urinary oestrone conjugates (E1C) and non-specific progesterone metabolites (iPdG) in samples collected in October, 1988, revealed that none of the 18 mares that received 3 and only 1 of the 6 mares that received two inoculations were pregnant, whereas 3 of 6 sham-injected control mares and 5 of 11 untreated mares were pregnant. Read More
    Applications of pig zona pellucida immunocontraception to wildlife fertility control.
    J Reprod Fertil Suppl 1996 ;50:183-9
    Zoo Montana, Billings, MT 59108, USA.
    A unique application of pig zona pellucida (PZP) immunocontraception is the control of wildlife populations. A native PZP vaccine has been successfully applied to wild horse and donkey populations. A single annual booster inoculation was capable of maintaining contraception. Read More
    Serum antibody immunoreactivity to equine zona protein after SpayVac vaccination.
    Theriogenology 2015 Jul 24;84(2):261-7. Epub 2015 Mar 24.
    Animal Reproduction and Biotechnology Laboratory, Colorado State University, Fort Collins, Colorado, USA. Electronic address:
    Immunocontraception with porcine ZP (pZP) can be an effective means of fertility control in feral horses. Previous studies suggest that antibodies produced after pZP vaccination may both inhibit fertilization and cause follicular dysgenesis. Zonastat-H, PZP-22, and SpayVac are three pZP vaccines proposed for use in horses. Read More
    Porcine zona pellucida (PZP) immunocontraception of wild horses (Equus caballus) in Nevada: a 10 year study.
    Reprod Suppl 2002 ;60:177-86
    Physiology and Molecular Medicine, Medical College of Ohio, Toledo 43614-5804, USA.
    Porcine zona pellucida (PZP) immunocontraception was investigated for possible use in free-roaming wild horses in the western USA. A protocol of two injections (3-4 weeks apart) of vaccine lasting 1 year was first used and a single-injection controlled-release vaccine of 1 year duration was developed and tested in the field. Studies of a presumptive vaccine of 2 year duration were initiated. Read More